欧盟 - 冰岛文 - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - bóluefni - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirus sýkingar - veirueyðandi lyf til almennrar notkunar - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Íhuga ætti að opinbera leiðsögn á réttri notkun af veirum.

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm healthcare a/s - furosemidum inn - tafla - 40 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - piroxicamum inn - hlaup - 0,5 %

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm healthcare a/s - furosemidum inn - tafla - 20 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - amoxicillinum tríhýdrat; potassium clavulanate - filmuhúðuð tafla - 875/125 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - amoxicillinum tríhýdrat; acidum clavulanicum kalíum - mixtúruduft, dreifa - 80/11,4 mg/ml

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - cytarabinum inn - stungulyf/innrennslislyf, lausn - 100 mg/ml

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

mcneil sweden ab - miconazolum nítrat; hydrocortisonum inn - krem

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - methylprednisolonum acetat - stungulyf, dreifa - 40 mg/ml